Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,483 | 2,749 | 1,500 | 3,322 | 1,871 |
| Cost of Goods | 862 | 1,775 | 1,057 | 1,273 | 914 |
| Gross Profit | 621 | 974 | 443 | 2,049 | 957 |
| Operating Expenses | 3,806 | 4,102 | 4,117 | 4,483 | 8,164 |
| Operating Income | -2,323 | -2,353 | -3,617 | -2,161 | -6,293 |
| Interest Expense | 43 | 23 | 70 | 22 | 22 |
| Other Income | 547 | -324 | 32 | -3,466 | 448 |
| Pre-tax Income | -1,819 | -2,700 | -3,655 | -5,649 | -5,867 |
| Income Tax | N/A | -1 | N/A | 1,082 | -112 |
| Net Income Continuous | -1,819 | -2,701 | -3,655 | -6,731 | -5,755 |
| Net Income | $-1,819 | $-2,701 | $-3,655 | $-6,731 | $-5,755 |
| EPS Basic Total Ops | -0.57 | -0.85 | -1.16 | -2.68 | -1.85 |
| EPS Basic Continuous Ops | -0.57 | -0.85 | -1.16 | -2.68 | -1.85 |
| EPS Diluted Total Ops | -0.57 | -0.85 | -1.16 | -2.68 | -1.85 |
| EPS Diluted Continuous Ops | -0.57 | -0.85 | -1.16 | -2.68 | -1.85 |
| EPS Diluted Before Non-Recurring Items | -0.57 | -0.85 | -1.16 | -2.15 | -1.85 |
| EBITDA(a) | $-2,034 | $-2,155 | $-3,317 | $-2,586 | $-5,853 |